Novo Nordisk
PulseAugur coverage of Novo Nordisk — every cluster mentioning Novo Nordisk across labs, papers, and developer communities, ranked by signal.
2 天有情绪数据
-
European, US markets open; Novo Nordisk weight-loss drug plans
The article discusses the opening of European and US stock markets for the week, Novo Nordisk's strategies for its weight-loss drug, and South Korea's potential use of extraordinary tax revenues from AI-profiting compan…
-
Zuckerberg-backed AI firm acquires Parkinson's therapy from Ozempic maker
Cellular Intelligence, an AI startup funded by Mark Zuckerberg, has acquired the rights to an experimental Parkinson's cell therapy from Novo Nordisk, the pharmaceutical company known for Ozempic. This acquisition signi…
-
开源工具赋予AI完全访问制药研发数据的权限
一个名为drug-pipeline-mcp的开源项目已发布，为AI代理提供对制药研发数据的全面访问。该工具聚合了临床试验、FDA/EMA批准、安全报告、药品标签、专利到期、召回和PubMed出版物的信息。该项目旨在为AI提供对药物开发管线的深入见解，能够进行诸如“Novo Nordisk的管线中有哪些？”之类的查询。该计划已获得MIT许可，并在GitHub上可用。
-
Corporate America defies economic uncertainty with strong Q1 earnings
Corporate America is demonstrating resilience during the current earnings season, with a significant majority of S&P 500 companies exceeding profit expectations. This performance is occurring despite economic headwinds …
-
Seres reports 33,132 new energy vehicle sales in April, up 5.22%
Seres announced its April sales figures, reporting 33,132 new energy vehicles sold, a 5.22% increase year-over-year. For the first four months of the year, cumulative sales reached 111,632 vehicles, marking a 29.74% yea…